Friday July 20, 2018

Feeding cow’s milk to toddlers below 1 year is harmful to them, says Experts

Feeding Cow's milk to toddlers below one year can lead to allergic diseases

0
//
39
Feeding cow's milk to toddlers below 1 year is harmful
Feeding cow's milk to toddlers below 1 year is harmful. Pixabay
Republish
Reprint
  • Though cow’s milk is associated with our culture for ages, it should not be given to toddlers below one year
  • Cow’s Milk may put a strain on the infant’s immature kidney and is also difficult to digest
  • Only 40 % of children were introduced timely complementary foods, while only 10 % children between six to 23 months received adequate diets

New Delhi, September 10, 2017: Feeding cow’s milk to toddlers below the age of one year is a growing factor behind allergic diseases, including in the respiratory and digestive system, as they cannot tolerate the protein in the milk, experts said on Sunday.

Stating that infants who do not get breast milk need an alternate form of nutrition to maintain their health, the child experts said if cow’s milk is fed at such an initial age then the low concentration of iron and its consumption during infancy is linked to anemia.

“Though cow’s milk is associated with our culture for ages, it should not be given to toddlers below one year… It may put a strain on the infant’s immature kidney and is also difficult to digest,” said Nandan Joshi, Health and Nutrition Science, Danone India.

While older infants can be fed with household complimentary food, younger ones need special hydrolyzed and amino acid-based formula which does not produce allergy.

As per the National Family Health Survey (NFHS), only 40 per cent of children were introduced timely complementary foods, while only 10 per cent children between six to 23 months received adequate diets.

The infants are given cow milk in India as awareness is low among the people, especially in rural areas.

As per the Rapid Survey on Children (RSOC), 42 per cent of nonbreastfed infants below one year received cow’s milk or any other milk.

“Allergic diseases are on the rise worldwide. The incidents are more in developed countries though it is on the rise in India as well. Milk allergy is the most common allergy in children,” said Lalit Bharadia, Consultant Paediatric Gastroenterologist at Jaipur’s Santokba Durlabhji Memorial Hospital.

“Around 3 per cent of children can’t tolerate milk protein in animal milk. Milk allergic infants, who do not get breast milk, need an alternate form of nutrition to maintain their health.”

Durlabhji said that while older infants can be fed with household complimentary food, younger ones need special hydrolyzed and amino acid-based formula which does not produce allergy.

“Such products are easily available in India.”

Allergy is a result of one or more cow’s milk proteins triggering an adverse reaction by our body’s immune system.

The symptoms vary and may affect several organ systems such as skin, digestive or the respiratory tract, possibly resulting in skin rash, eczema, vomiting, diarrhoea, colic, wheezing or excessive crying.

In a study conducted at a tertiary care hospital in India, three out of 10 children with chronic diarrhoea were estimated to be suffering from cow’s milk allergy. Globally, the prevalence rate of cow’s milk allergy is approximately 3 to 5 per cent. (IANS)

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Study Shows Eczema Drug is Effective Against Severe Asthma

An eczema drug may help alleviate asthma symptoms as well as improve patients' lung function better than standard therapies, results from twin studies have shown.

0
Asthma
Asthma Patients May be Over-Medicating. Wikimedia Commons

An eczema drug may help alleviate asthma symptoms as well as improve patients’ lung function better than standard therapies, results from twin studies have shown.

Dupilumab, an injectable anti-inflammatory drug, was approved in 2017 by the US Food and Drug Administration as a treatment for eczema, a chronic skin disease.

The findings showed that the rate of asthma exacerbations — such as such as wheezing, coughing, shortness of breath and tightness in the chest — was almost cut in half for those taking dupilumab compared with those taking a placebo.

“This drug not only reduced severe symptoms of asthma, it improved the ability to breathe,” said Mario Castro, Professor at the Washington University in St. Louis.

“That’s important because these patients have a chronic disabling disease that worsens over time with the loss of lung function. So far, we do not have a drug for asthma that changes the course of the disease,” Castro added.

By joining two drugs, one of Arthritis could be solution to skin cancer: Wikimedia commons

Although the drug significantly reduced asthma symptoms for all patients, dupilumab worked particularly well in patients with high numbers of a specific type of white blood cell, called eosinophils, circulating in the bloodstream.

For those patients, asthma exacerbations were cut by two-thirds, the researchers said.

The drug also helped wean severe asthma patients off of chronic oral steroids, which can cause debilitating long-term side effects, including stunted growth, diabetes, cataracts and osteoporosis, Castro said.

For the studies, published in The New England Journal of Medicine, the team included more than 2,000 patients who suffered from moderate to severe asthma.

Also Read: Mother’s vitamin B levels during pregnancy may affect child’s Eczema risk

In patients with moderate to severe asthma who used at least three different inhalers to control their symptoms, dupilumab drug, regardless of dose, improved lung function by approximately 130-200 milliliters greater than those receiving the placebo.

The drug also improved their rates of emergency room (ER) visits and hospitalizations. (IANS)